Tatva Chintan Pharma Chem (TATVA) Share Price Falls 8.81% Today
- October 22, 2026
- Posted by: Kunal Singla
- Category: News
Tatva Chintan Share Price fell 8.81% to Rs 1,716.25, and the company’s market capitalisation stood at Rs 4,444.61 Cr as of 22 October 2026 at 9:53:17 AM IST. The move places Tatva Chintan Pharma Chem in focus as a Small Cap chemicals name, with Tatva Chintan Share Price Today reflecting a sharp intraday decline from the previous close. Univest data confirms the move itself, though no company-specific trigger has been identified. That makes Tatva Chintan Share Price News relevant for investors who want to separate the day’s price action from the company’s underlying numbers. Univest data also shows that the stock is being tracked alongside valuation, profitability and sector benchmarks rather than on any unsupported explanation.
Tatva Chintan Pharma Chem (TATVA) Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 1,716.25 |
| Previous Close | Rs 1,882.1 |
| Today's Move | -Rs 165.85 (-8.81%) |
| Open | Rs 1,830 |
| High | Rs 1,835.35 |
| Low | Rs 1,675 |
| Market Capitalisation | Rs 4,444.61 crore |
| Market Cap Category | Small Cap |
Tatva Chintan Share Price Today opened at Rs 1,830, touched a high of Rs 1,835.35 and a low of Rs 1,675, before last trading at Rs 1,716.25. The previous close was Rs 1,882.10, so the share price fall amounted to Rs 165.85, or 8.81%. The stock therefore moved well below the prior close and stayed within a wide intraday band, with the low sitting much closer to the day’s last traded level than the opening print. Market capitalisation remained Rs 4,444.61 Cr, and the stock sits in the Small Cap category. In Univest terms, Tatva Chintan Share Price Today is an event-led move that deserves attention because the change is large relative to the current price level and because the day’s range is clear enough to map the intraday price action precisely. That sets up the fundamental view next.
Tatva Chintan Pharma Chem (TATVA) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 4,444.61 crore |
| P/E Ratio | 69.97x |
| P/B Ratio | 5.4x |
| ROE | 5.53% |
| ROCE | 7.17% |
| EPS | Rs 26.9 |
| Book Value Per Share | Rs 348.26 |
| Dividend Yield | 0.11% |
Tatva Chintan Pharma Chem (TATVA) fundamental metrics show P/E 69.97x, P/B 5.4x, ROE 5.53%, ROCE 7.17%. Read together, these ratios describe the company’s position rather than a recommendation.
Tatva Chintan Pharma Chem has a market capitalisation of Rs 4,444.61 crore and falls in the Small Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 69.97x, P/B at 5.4x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 5.53% and ROCE of 7.17%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 26.9, book value per share of Rs 348.26, dividend yield of 0.11%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 25.18x, median ROE of 8.22%, median ROCE of 10.64%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Chemicals |
| Industry | Chemicals |
| Benchmark Scope | same industry |
| Company P/E Ratio | 69.97x |
| Benchmark Median P/E | 25.18x |
| Benchmark Average P/E | 49.55x |
| Benchmark P/E Range | 3.91x to 849.84x |
| Company P/B Ratio | 5.4x |
| Benchmark Median P/B | 1.8x |
| Benchmark Average P/B | 2.55x |
| Company ROE | 5.53% |
| Benchmark Median ROE | 8.22% |
| Benchmark Average ROE | -3.57% |
| Company ROCE | 7.17% |
| Benchmark Median ROCE | 10.64% |
| Benchmark Average ROCE | 11.6% |
| Company Market Capitalisation | Rs 4,444.61 crore |
| Benchmark Median Market Cap | Rs 459.55 crore |
| Benchmark Average Market Cap | Rs 5,136.57 crore |
Tatva Chintan Pharma Chem (TATVA) operates in the Chemicals sector, within the Chemicals industry.
Tatva Chintan Pharma Chem (TATVA) has a P/E ratio of 69.97x, which is above the benchmark median of 25.18x, a difference of +177.88%. The P/E comparison frames valuation; it is not a signal to buy or sell.
Tatva Chintan Pharma Chem (TATVA) has a ROE of 5.53%, which is below the benchmark median of 8.22%, a difference of -32.73%. Tatva Chintan Pharma Chem (TATVA) has a ROCE of 7.17%, which is below the benchmark median of 10.64%, a difference of -32.61%.
Track stocks among today's decliners through the Univest top decliners screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Solar Industries India | SOLARINDS | 1,78,992.04 | 87.19 | 25.04 | 32.49 | 38.16 |
| Pidilite Industries | PIDILITIND | 1,50,952.3 | 56.41 | 12.92 | 24.29 | 32.38 |
| SRF | SRF | 71,800.02 | 30.08 | 4.65 | 13.8 | 14.21 |
| Gujarat Fluorochemicals | FLUOROCHEM | 48,899.18 | 78.21 | 5.99 | 7.65 | 9.58 |
| Navin Fluorine International | NAVINFLUOR | 41,841.77 | 52.07 | 9.79 | 20.24 | 21.39 |
Tatva Chintan Pharma Chem (TATVA) has a P/E ratio of 69.97x compared with the displayed peer median of 56.41x. Peer multiples give relative context only, not a buy or sell view. Its ROE of 5.53% compares with a peer median of 20.24% across the companies shown in the table. ROCE stood at 7.17% versus the displayed peer median of 21.39%, providing a capital-efficiency comparison. Tatva Chintan Pharma Chem (TATVA) has a market capitalisation of Rs 4,444.61 crore. All 5 peers shown have a larger market capitalisation.
Why Investors Are Watching Tatva Chintan Pharma Chem
- Tatva Chintan Share Price is down 8.81% today, making the move large enough to stay on stock-watch lists.
- The last traded price of Rs 1,716.25 sits well below the previous close of Rs 1,882.10.
- The stock’s P/E of 69.97 is above the chemicals benchmark median of 25.18.
- ROE of 5.53% and ROCE of 7.17% are below the sector medians.
- Market capitalisation of Rs 4,444.61 Cr keeps Tatva Chintan Share Price in the Small Cap bracket.
About Tatva Chintan Pharma Chem
Tatva Chintan Pharma Chem operates in the Chemicals sector and Chemicals industry. The company is known in the market for specialty chemical exposure, and its stock is tracked for valuation, return ratios and company financials within the broader chemicals space. Tatva Chintan Share Price is therefore watched alongside revenue quality, book value, EPS and dividend yield rather than on price alone. With a market capitalisation of Rs 4,444.61 Cr, the company is positioned as a Small Cap chemical business in Univest coverage. For investors scanning Tatva Chintan Share Price News, the key point is that the company’s market position, profitability metrics and peer comparison all matter together.
Track Tatva Chintan Share Price on Univest
Use Tatva Chintan Pharma Chem (TATVA) live share-price page, Univest top decliners screener, Univest market blogs to review live stock data, top decliners and related market analysis.
You can track Tatva Chintan Share Price on Univest for live price updates, fundamental ratios, 52-week levels and market insights in one place. Univest also helps readers follow Tatva Chintan Share Price Today alongside sector context, company financials and peer positioning. If Tatva Chintan Share Price continues to move sharply, Univest provides a clean way to review the same figures without mixing them with unsupported commentary. For investors and market readers, that makes Univest a useful reference point for Tatva Chintan Share Price updates and stock analysis.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).
Frequently Asked Questions
Why did Tatva Chintan Share Price fall today?
Ans. Tatva Chintan Share Price fell 8.81% to Rs 1,716.25. Univest data confirms the move itself, though no company-specific trigger has been identified. The move is best read with valuation, return ratios and peer benchmarks.
What is Tatva Chintan Share Price Today?
Ans. Tatva Chintan Share Price Today stood at Rs 1,716.25 as of 22 October 2026 at 9:53:17 AM IST. It was below the previous close of Rs 1,882.10 after a decline of Rs 165.85.
How much did Tatva Chintan Share Price move in percentage terms?
Ans. Tatva Chintan Share Price declined 8.81% in the latest move. That change followed an opening price of Rs 1,830, with the stock also touching Rs 1,835.35 and Rs 1,675 during the move.
What is the market capitalisation of Tatva Chintan Pharma Chem?
Ans. Tatva Chintan Pharma Chem had a market capitalisation of Rs 4,444.61 Cr. Univest classifies it as a Small Cap, which helps frame Tatva Chintan Share Price in company-size context rather than as a valuation signal.
How is Tatva Chintan Share Price valued against the chemicals sector?
Ans. Tatva Chintan Share Price carries a P/E ratio of 69.97 and a P/B ratio of 5.4. Both are above the chemicals benchmark median, which places the stock in a richer valuation band than the industry middle.
What do the ROE and ROCE figures show for Tatva Chintan Share Price?
Ans. Tatva Chintan Share Price is backed by ROE of 5.53% and ROCE of 7.17%. Both are below the chemicals benchmark medians, so the stock’s return profile is weaker than the industry midpoint.
What do EPS and book value mean for Tatva Chintan Share Price?
Ans. Tatva Chintan Share Price includes EPS of Rs 26.9 and book value of Rs 348.26 per share. EPS reflects earnings attributable to each share, while book value shows accounting net worth per share.
Does Tatva Chintan Share Price offer any dividend yield?
Ans. Tatva Chintan Share Price has a dividend yield of 0.11%. That is a small yield, so investors generally read it as a minor part of the overall stock view rather than the main investment case.
How does Tatva Chintan Share Price compare with peers?
Ans. Tatva Chintan Share Price has a P/E above SRF, Godrej Industries, Deepak Nitrite and Atul, but below Solar Industries and Gujarat Fluorochemicals. Its ROE and ROCE also trail several stronger chemical peers.
